Skip to content
value.today

ShockWave Medical, Inc.

Total raised
$145 M
4 rounds on record
Latest round
$10 M
Mar 2019
First round on record
May 2015
Today
Acquired
Acquired by Johnson & Johnson

Acquired

Matched to this startup by its exact name; the buyer's report is the source.

Acquisition of ShockWave Medical, Inc.
AcquiredBuyerAcquisition dateCompletionPriceStakeSource
Shockwave Medical, IncJohnson & Johnson2024—$12.6 B—Annual report

Funding rounds

4 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of ShockWave Medical, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Mar 2019$10 MNo. 4$10 to $50 million

ShockWave Medical, Inc.: Raise no. 4, Mar 2019

Investors in this round

1 investor had bought by the notice of Mar 19, 2019: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 14 investors are named for ShockWave Medical, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$10 M of $10 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Dan Puckett · Executive Officer
  • Douglas Godshall · Executive Officer, Director
  • Isaac Zacharias · Executive Officer
  • Antoine Papiernik · Director
  • Colin Cahill · Director
  • Frederic Moll · Director
  • Jay Watkins · Director
  • Laura Francis · Director
  • Raymond Larkin · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Douglas Godshall, President and CEO. Source: SEC Form D, newest notice filed Mar 19, 2019. Read the notice at the SEC.

equitySEC
Dec 2018$15 MNo. 3$10 to $50 million

ShockWave Medical, Inc.: Raise no. 3, Dec 2018

Investors in this round

1 investor had bought by the notice of Dec 14, 2018: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 14 investors are named for ShockWave Medical, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$15 M of $16 M offered; $1 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Dan Puckett · Executive Officer
  • Douglas Godshall · Executive Officer, Director
  • Isaac Zacharias · Executive Officer
  • Antoine Papiernik · Director
  • Colin Cahill · Director
  • Frederic Moll · Director
  • Jay Watkins · Director
  • Marc-Andre Marcotte · Director
  • Todd Brinton · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by /s/ Douglas Godshall, President and CEO. Source: SEC Form D, newest notice filed Dec 14, 2018. Read the notice at the SEC.

equitySEC
Nov 2016$80 MNo. 2$50 to $250 million

ShockWave Medical, Inc.: Raise no. 2, Nov 2016

Investors in this round

27 investors had bought by the notice of Oct 10, 2017: 27 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 14 investors are named for ShockWave Medical, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$80 M of $80 M offered
Smallest investment taken
$1
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Dan H. Puckett · Executive Officer
  • Doug Godshall · Executive Officer, Director
  • Antoine H. Papiernik · Director
  • Colin H. Cahill · Director
  • Frederic H. Moll · Director
  • Jay H. Watkins · Director
  • Michael H. Sjostrom · Director
  • Todd J. Brinton · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Doug Godshall, President. Source: SEC Form D and 1 amendment, newest notice filed Oct 10, 2017. Read the notice at the SEC.

equitySEC
May 2015$40 MNo. 1$10 to $50 million

ShockWave Medical, Inc.: Raise no. 1, May 2015

Investors in this round

29 investors had bought by the notice of May 22, 2015: 29 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 14 investors are named for ShockWave Medical, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$40 M of $40 M offered; $0 M still to sell
Smallest investment taken
$1
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Daniel Hawkins · Executive Officer, Director
  • Antoine H. Papiernik · Director
  • Colin H. Cahill · Director
  • Frederic H. Moll · Director
  • Jay H. Watkins · Director
  • Todd J. Brinton · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Daniel Hawkins, President. Source: SEC Form D, newest notice filed May 22, 2015. Read the notice at the SEC.

equity, optionsSEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • ShockWave Medical, Inc. chose not to state its revenue in its newest notice of a funding round (Mar 2019).

    SEC Form D · Mar 2019

  • The industry group it chose in its notices: Other Health Care.

    SEC Form D · Mar 2019

That is all the official record says: ShockWave Medical, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

14 named in official filings. Open an investor to see everything it has backed.

Investors in ShockWave Medical, Inc.
InvestorKindAmountRoundRoleSource
Deerfield Management Company, L.P.Fund or asset managernot statednot statedHeld Series B and C preferred stock, 10% owner (Form 3, 2019)SEC Form 3
Deerfield Mgmt III, L.P.Fund or asset managernot statednot statedHeld Series B and C preferred stock, 10% owner (Form 3, 2019)SEC Form 3
Deerfield Mgmt L.P.Fund or asset managernot statednot statedHeld Series B and C preferred stock, 10% owner (Form 3, 2019)SEC Form 3
Deerfield Private Design Fund III, L.P.Fund or asset managernot statednot statedHeld Series B and C preferred stock, 10% owner (Form 3, 2019)SEC Form 3
Deerfield Special Situations Fund, L.P.Fund or asset managernot statednot statedHeld Series B and C preferred stock, 10% owner (Form 3, 2019)SEC Form 3
Frank T. WatkinsPersonnot statednot statedHeld Series A-1 and B preferred stock, director (Form 3, 2019)SEC Form 3
Frederic H. MollPersonnot statednot statedHeld Series A, A-1, B and C preferred stock, director (Form 3, 2019)SEC Form 3
Sofinnova Capital VII FCPRFund or asset managernot statednot statedHeld Series A-1, B and C preferred stock, 10% owner (Form 3, 2019)SEC Form 3
Venrock Associates VII, L.P.Fund or asset managernot statednot statedHeld Series B and C preferred stock, 10% owner (Form 3, 2019)SEC Form 3
Venrock Healthcare Capital Partners II, L.P.Fund or asset managernot statednot statedHeld Series B and C preferred stock, 10% owner (Form 3, 2019)SEC Form 3
Venrock Management VII, LLCFund or asset managernot statednot statedHeld Series B and C preferred stock, 10% owner (Form 3, 2019)SEC Form 3
Venrock Partners VII, L.P.Fund or asset managernot statednot statedHeld Series B and C preferred stock, 10% owner (Form 3, 2019)SEC Form 3
VHCP Co-Investment Holdings II, LLCFund or asset managernot statednot statedHeld Series B and C preferred stock, 10% owner (Form 3, 2019)SEC Form 3
VHCP Management II, LLCFund or asset managernot statednot statedHeld Series B and C preferred stock, 10% owner (Form 3, 2019)SEC Form 3

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 4 rounds above had up to 29 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by ShockWave Medical, Inc.
NameRoleNamed in
Dan PuckettExecutive officerMar 2019
Douglas GodshallExecutive officerMar 2019
Isaac ZachariasExecutive officerMar 2019
Dan H. PuckettExecutive officerOct 2017
Doug GodshallExecutive officerOct 2017
Daniel HawkinsExecutive officerNov 2016
Antoine PapiernikDirectorMar 2019
Colin CahillDirectorMar 2019
Douglas GodshallDirectorMar 2019
Frederic MollDirectorMar 2019
Jay WatkinsDirectorMar 2019
Laura FrancisDirectorMar 2019
Raymond LarkinDirectorMar 2019
Marc-Andre MarcotteDirectorDec 2018
Todd BrintonDirectorDec 2018
Antoine H. PapiernikDirectorOct 2017
Colin H. CahillDirectorOct 2017
Doug GodshallDirectorOct 2017
Frederic H. MollDirectorOct 2017
Jay H. WatkinsDirectorOct 2017
Michael H. SjostromDirectorOct 2017
Todd J. BrintonDirectorOct 2017
Daniel HawkinsDirectorNov 2016

Acquired (Jan 1, 2024). Acquired by Johnson & Johnson.